Antierythrocyte_autoantibody_formation_after_therapy_with_interleukin-2_and_gamma-interferon._The_cardiovascular,_renal,_pulmonary,_and_dermatologic_toxicities_of_interleukin-2_(IL-2)_and_gamma-interferon_(IFN)_are_well_described._However,_autoimmune_toxicities_have_only_recently_been_noticed._The_authors_report_the_development_of_warm_autoantibodies_against_erythrocytes_in_a_patient_receiving_IL-2_(3.75_x_10(6)_cetus_units/m2_intravenous_bolus_three_times_per_week)_and_gamma-IFN_(0.1_mg/m2_subcutaneously_three_times_per_week)_for_metastatic_renal_cell_carcinoma._Other_potential_causes_of_autoantibody_formation,_such_as_drugs,_infection,_and_collagen_vascular_disease,_were_excluded._Both_gamma-IFN_and_IL-2_have_the_potential_to_trigger_or_exacerbate_autoimmunity_due_to_either_aberrant_expression_of_restricted_antigens_or_inhibition_of_normal_cellular_immune_suppressor_mechanisms.